Boeing, Nurix Therapeutics And 3 Stocks To Watch Heading Into Monday
Portfolio Pulse from Avi Kapoor
Several stocks are in focus as U.S. stock futures trade slightly lower. Karooooo Ltd. is expected to report earnings, Innate Pharma appointed a new CEO, Nurix Therapeutics beat earnings expectations, Boeing reported a significant loss and workforce reduction, and China Liberal Education reported a loss.
October 14, 2024 | 6:35 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Boeing reported a preliminary Q3 loss of $9.97 per share and $17.8 billion in revenue, alongside a 10% workforce reduction. Shares fell 0.9%.
The significant loss and workforce reduction are likely to negatively impact investor sentiment, leading to a short-term price decrease.
CONFIDENCE 95
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
China Liberal Education reported a first-half loss of $2.04 per share, compared to a previous profit. Shares fell 2.8% in after-hours trading.
The transition from profit to loss is likely to negatively impact investor sentiment, resulting in a short-term price decrease.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Innate Pharma appointed Jonathan Dickinson as CEO, effective Nov. 1. Shares rose 5.6% following the announcement.
The appointment of a new CEO often leads to positive investor sentiment, reflected in the share price increase.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Karooooo Ltd. is expected to report quarterly earnings of 39 cents per share on $63.23 million revenue. Shares rose 14.4% in after-hours trading.
The significant after-hours price increase suggests positive investor sentiment ahead of the earnings report, indicating a likely short-term price increase.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Nurix Therapeutics reported a smaller-than-expected loss of 67 cents per share, beating estimates. Shares gained 2% in after-hours trading.
Beating earnings expectations typically results in positive investor sentiment, leading to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 65
RELEVANCE 75